Biotech Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Centers for Disease Control & Prevention
Opsonophagocytosis assay effective for Streptococcus pneumoniae antibodies
January 14th, 2004
Scientists have developed an opsonophagocytosis assay for measurement of opsonophagocytic antibodies specific to the capsular polysaccharides of Streptococcus pneumoniae. "Opsonophagocytosis is a correlate of protection that measures the functional activity of vaccine-induced antibodies. A standardized opsonophagocytosis assay (OPA) should be used as part of the evaluation of current and future pneumococcal (Pnc) polysaccharide (Ps)-based vaccines. We enrolled five laboratories to evaluate a previously standardized viability OPA," scientists writing in the journal Clinical and Diagnostic Laboratory Immunology report. "Each laboratory...
Source: Biotech Week (2004-01-14)
|
